Last updated: February 23, 2026
What is NDC 00781-5223?
NDC 00781-5223 refers to Sodium Chloride Injection, USP (0.9%), used primarily for intravenous repletion of sodium in hospitalized patients, volume resuscitation, and as a diluent for medications.
Market Size and Demand
Current Market Status
- The global saline solutions market was valued at approximately USD 2.4 billion in 2022.
- A compound annual growth rate (CAGR) of 5.2% is projected from 2023 to 2030.
- The primary consumers are hospitals, clinics, and outpatient surgery centers.
Key Factors Influencing Demand
- Hospitalization rates influence saline needs.
- Expansion of ambulatory care increases usage.
- Increased focus on sterility and safety boosts demand for USP-grade saline.
Market Segments
| Segment |
Estimated Volume (2022) |
Projected CAGR (2023–2030) |
Notes |
| Hospital use |
60% |
4.8% |
Largest consumer; hospital inventories crucial |
| Outpatient clinics |
25% |
6.0% |
Rapid growth in outpatient therapy |
| Emergency services |
15% |
5.0% |
Urgent infusion needs |
Geographic Distribution
| Region |
Market Share |
Growth Rate (2023–2030) |
Notes |
| North America |
45% |
4.5% |
Largest market, driven by hospital demand |
| Europe |
25% |
5.2% |
Strong hospital infrastructure |
| Asia-Pacific |
20% |
6.3% |
Rapidly expanding healthcare sector |
| Rest of World |
10% |
5.0% |
Emerging markets |
Current Pricing Landscape
Wholesale and Contract Pricing
- Average wholesale price per 100 mL vial: USD 0.30–0.50.
- Larger containers (1,000 mL): USD 1.50–2.50.
- Contract prices through hospital purchasing organizations (GPOs) lower by 10–15%.
Retail Price Variability
Prices in retail pharmacy settings range from USD 1.00 to USD 2.50 per 100 mL, with higher prices in outpatient clinics and emergency care settings.
Price Trends and Projections (2023–2030)
Factors Impacting Pricing
- Increased supply chain costs (raw materials, manufacturing, logistics).
- Regulatory requirements for USP-grade saline.
- Volatility in raw water and salt mineral costs.
- Market consolidation among major suppliers.
Price Outlook
| Year |
Estimated Price per 100 mL |
Factors |
| 2023 |
USD 0.40 |
Stable supply, moderate inflation |
| 2025 |
USD 0.45–0.50 |
Rising raw material costs |
| 2030 |
USD 0.50–0.60 |
Potential supply chain constraints, inflation |
Competitive Landscape
Major Suppliers
| Company |
Market Share |
Capacity Expansion Plans |
Key Differentiators |
| Baxter International |
30% |
New plants in Asia |
Bulk manufacturing, price competitiveness |
| B. Braun |
25% |
Capacity upgrades in Europe |
Product quality, distribution network |
| Hospira (Pfizer) |
20% |
Recent capacity investments |
USP compliance, global reach |
| Others |
25% |
Geographic expansion |
Niche markets, specialized formulations |
Regulatory Environment
- USP (United States Pharmacopeia) standards govern manufacturing.
- Compliance with FDA (Food & Drug Administration) regulations is mandatory.
- Any changes in USP monograph specifications could impact production costs.
Risks and Opportunities
Risks
- Supply chain disruptions elevate raw material prices.
- Regulatory shifts or quality concerns may restrict supply.
- Market saturation could suppress prices.
Opportunities
- Growth in emerging markets increases demand.
- Technological advancements in large-volume infusion manufacturing could reduce costs.
- Expansion into sterile water or other saline derivatives.
Summary
- Stable core product in a growing global saline solutions market.
- Price projections indicate gradual increases driven by rising raw materials and manufacturing costs.
- Major players maintain significant market share through capacity investments and geographic expansion.
- Regulatory standards and supply chain stability will influence future pricing.
Key Takeaways
- Demand is driven by hospital, outpatient, and emergency care sectors.
- Market is mature with steady growth; prices are expected to rise modestly through 2030.
- Prices in wholesale markets hover around USD 0.30–0.50 per 100 mL, with retail prices up to USD 2.50.
- Competition focuses on capacity and geographic reach.
- Regulatory compliance remains a key cost factor and barrier to market entry.
FAQs
-
What factors most affect the price of saline solutions? Raw material costs, manufacturing costs, regulatory compliance, and supply chain logistics.
-
How will emerging markets impact demand and prices? Growing healthcare infrastructure and outpatient care in Asia-Pacific and Africa increase demand, potentially stabilizing or lowering prices through competition.
-
What is the competitive advantage of major suppliers? Capacity expansion, cost efficiencies, and wide-reaching distribution networks.
-
Are there new technologies influencing saline market prices? Large-volume infusion manufacturing and improved sterilization processes may reduce costs over time.
-
What regulatory changes could impact future pricing? Stricter USP standards or FDA requirements could raise manufacturing costs, impacting prices.
References
[1] MarketsandMarkets. (2022). Saline Solutions Market. Retrieved from https://www.marketsandmarkets.com
[2] Grand View Research. (2023). Infusion Therapy Market. Retrieved from https://www.grandviewresearch.com
[3] U.S. Food and Drug Administration. (2022). USP Standards and Compliance. Retrieved from https://www.fda.gov
[4] IQVIA. (2022). Global Healthcare Market Data. Retrieved from https://www.iqvia.com
[5] Statista. (2023). Healthcare Market Trends. Retrieved from https://www.statista.com
